amantadine has been researched along with Epilepsy in 9 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Literature searches were conducted utilizing PubMed and MEDLINE databases employing combinations of search terms including, but not limited to, "epilepsy", "refractory", "seizure", and the following medications: acetazolamide, amantadine, bumetanide, imipramine, lidocaine, verapamil, and various stimulants." | 4.95 | Outside the box: Medications worth considering when traditional antiepileptic drugs have failed. ( Perry, MS; Turner, AL, 2017) |
| "The authors administered to 18 children with an expressed pharmaco-resistant Lennox-Gastaut syndrome as adjuvant treatment medium doses of amantadine (Viregyt-K, Egyt), 8 mg/kg/day divided into 1-2 portions or L-DOPA (Nakom, Lek) 22 mg/kg/day in 3-4 portions." | 3.67 | [Therapeutic effect of dopaminergic substances in drug-resistant Lennox-Gastaut syndrome]. ( Slapal, R; Zouhar, A, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turner, AL | 1 |
| Perry, MS | 1 |
| Szakács, R | 1 |
| Weiczner, R | 1 |
| Mihály, A | 1 |
| Krisztin-Péva, B | 1 |
| Zádor, Z | 1 |
| Zádor, E | 1 |
| Gilbert, JC | 1 |
| Miras Portugal, MT | 1 |
| Aunis, D | 1 |
| Mandel, P | 1 |
| Warter, JM | 1 |
| Coquillat, G | 1 |
| Collard, M | 1 |
| Rohmer, F | 1 |
| Slapal, R | 1 |
| Zouhar, A | 1 |
| Mehta, VL | 1 |
| Bhalla, S | 1 |
| Wafai, ZA | 1 |
| Wallnöfer, H | 1 |
| Schiller, L | 1 |
| Florio, V | 1 |
1 review available for amantadine and Epilepsy
| Article | Year |
|---|---|
Outside the box: Medications worth considering when traditional antiepileptic drugs have failed.
Topics: Amantadine; Anticonvulsants; Bumetanide; Central Nervous System Stimulants; Epilepsy; Humans; Imipra | 2017 |
8 other studies available for amantadine and Epilepsy
| Article | Year |
|---|---|
Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex.
Topics: 4-Aminopyridine; Amantadine; Animals; Behavior, Animal; Cerebral Cortex; Dizocilpine Maleate; Dopami | 2003 |
Diseases of the central nervous system. Pharmacological basis of treatment.
Topics: Amantadine; Analgesics, Opioid; Anticonvulsants; Blood-Brain Barrier; Central Nervous System Disease | 1975 |
[Dopamine beta hydroxylase. Value and limits of its study in neurology].
Topics: Amantadine; Cold Temperature; Dopamine beta-Hydroxylase; Epilepsy; Humans; Levodopa; Movement Disord | 1976 |
[Therapeutic effect of dopaminergic substances in drug-resistant Lennox-Gastaut syndrome].
Topics: Amantadine; Child, Preschool; Epilepsy; Humans; Infant; Levodopa; Syndrome | 1989 |
Attenuation of pentylenetetrazol kindling of epileptogenesis in rats by dopaminergic agents.
Topics: Amantadine; Amphetamine; Animals; Epilepsy; Haloperidol; Kindling, Neurologic; Levodopa; Male; Metoc | 1988 |
[Aminoadamantane therapy in comatose conditions].
Topics: Adult; Aged; Amantadine; Coma; Epilepsy; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged | 1974 |
[Study of the central action of amantadine].
Topics: Amantadine; Animals; Butyrophenones; Central Nervous System; Chlorpromazine; Dihydroxyphenylalanine; | 1971 |
Concurrent session: current trends in neurology and psychiatry.
Topics: Amantadine; Behavior Therapy; Dihydroxyphenylalanine; Epilepsy; Female; Humans; Male; Neurology; Par | 1971 |